Last update: July 2, 2015
Minimal risk for breastfeeding and infant.
S-Enantiomer of Citalopram that shares similar pharmacokinetics and properties with Citalopram.
Excretion into breast milk is clinically non-significant. Serum levels of infants from breastfeeding mothers who were treated have been shown to be undetectable or very low.
Overall, short or long-term harmful effect has not been reported among breastfed infants. Isolated cases of irritability and neonatal necrotizing enterocolitis after intrauterine exposure have appeared in medical literature contrasting with harmlessness reported by others.
Galactorrhea associated or not to hyperprolactinemia, may appear.
Women who are on antidepressant treatment in pregnancy are in need of special and intensive support for breastfeeding because of a high risk of early weaning.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Instituto de Salud Infantil, Grecia-Institute of Child's Health in Greece
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM